bioRxiv ScienceSearch

bioRxiv · 10.1101/498964

Functional and Optogenetic Approaches to Discovering Stable Subtype-Specific Circuit Mechanisms in Depression

Abstract

BackgroundUsing canonical correlation analysis (CCA), hierarchical clustering, and machine learning methods, we recently identified four subtypes of depression defined by distinct patterns of abnormal functional connectivity in depression-related brain networks, which in turn predicted differing clinical symptom profiles and individual differences in treatment response. However, whether and how dysfunction in specific circuits may give rise to specific depressive symptoms and behaviors remains unclear. Furthermore, this approach assumes that there are robust and stable canonical correlations between functional connectivity and depressive symptoms--an assumption that was not extensively tested in our earlier work.\n\nMethodsFirst, we comprehensively re-evaluate the stability of canonical correlations between functional connectivity and symptoms, using optimized approaches for large-scale statistical testing, and we validate methods for improving stability. Next, we illustrate one approach to formulating hypotheses regarding subtype-specific circuit mechanisms driving depressive symptoms and behaviors and then testing them in animal models using optogenetic fMRI. We review recent work in this field and describe one example of this approach.\n\nResultsCorrelations between connectivity features and clinical symptoms are robustly significant, and CCA solutions tested repeatedly on held-out data generalize, but they are sensitive to data quality, preprocessing decisions, and clinical sample heterogeneity, which can reduce effect sizes. Generalization can be markedly improved by adding L2-regularization to CCA, which decreases variance, increases canonical correlations in left-out data, and stabilizes feature selection. This approach, in turn, can be used to identify candidate circuits for optogenetic interrogation in rodent models.\n\nConclusionsMulti-view approaches like CCA are a conceptually useful framework for discovering stable patient subtypes by synthesizing multiple clinical and functional measures. Optogenetic fMRI holds substantial promise for testing hypotheses regarding subtype-specific mechanisms driving specific symptoms and behaviors in depression.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Grosenick, L., Shi, T. C., Gunning, F., Dubin, M. J., Downar, J., Liston, C.. 2018-12-17. Functional and Optogenetic Approaches to Discovering Stable Subtype-Specific Circuit Mechanisms in Depression. https://doi.org/10.1101/498964

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience